Company & Sponsor Intelligence
Thomas Jefferson University
Evidence-linked intelligence derived from the current NeuroRisk clinical research corpus. Coverage reflects indexed source data and is not a claim of complete company activity.
Request enterprise analysis →Indexed trials6
Recruiting0
Completed1
Countries2
Therapeutic footprint
autismdepressionepilepsyother_neurologytraumatic_brain_injury
Indexed studies
NCT05504863RAPIDIRON Trial Follow-up Study: RAPIDIRON-KIDS Study
autism · IndiaUNKNOWN
autism · IndiaUNKNOWN
NCT00774306Antiepileptic Drugs and Vascular Risk Markers
epilepsy · NA
epilepsy · NA
NCT03829826Efficacy and Mechanism of Action of SCIg in Patients With Stiff Person Syndrome (SPS)
other_neurology · UNKNOWN
other_neurology · UNKNOWN
NCT02519998Tissue Repository and Master Database for Concussion Biomarker and Risk Calculator Development
traumatic_brain_injury · United StatesUNKNOWN
traumatic_brain_injury · United StatesUNKNOWN
NCT02454426Vortioxetine in Patients With Major Depressive Disorder and Coronary Artery Disease
depression · United StatesEARLY_PHASE1
depression · United StatesEARLY_PHASE1
NCT00269633Research Study of Treatment for Winter Depression With Different Colors of Light
depression · United StatesPHASE2
depression · United StatesPHASE2
Intelligence layer updated: 2026-10-29 06:17:44.639239+00:00
Enterprise intelligence
Compare sponsor activity, recruiting momentum, therapeutic exposure, geography and connected research signals across the neuroscience ecosystem.
Request comparative intelligence →